Literature DB >> 3988339

Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity.

T Hackstadt, M G Peacock, P J Hitchcock, R L Cole.   

Abstract

We isolated lipopolysaccharides (LPSs) from phase variants of Coxiella burnetii Nine Mile and compared the isolated LPS and C. burnetii cells by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting. The LPSs were found to be the predominant component which varied structurally and antigenically between virulent phase I and avirulent phase II. A comparison of techniques historically used to extract the phase I antigenic component revealed that the aqueous phase of phenol-water, trichloroacetic acid, and dimethyl sulfoxide extractions of phase I C. burnettii cells all contained phase I LPS, although the efficiency and specificity of extraction varied. Our studies provide additional evidence that phase variation in C. burnetii is analogous to the smooth-to-rough LPS variation of gram-negative enteric bacteria, with phase I LPS being equivalent to smooth LPS and phase II being equivalent to rough LPS. In addition, we identified a variant with a third LPS chemotype with appears to have a structural complexity intermediate to phase I and II LPSs. All three C. burnetii LPS contain a 2-keto-3-deoxyoctulosonic acid-like substance, heptose, and gel Limulus amoebocyte lysates in subnanogram amounts. The C. burnetii LPSs were nontoxic to chicken embryos at doses of over 80 micrograms per embryo, in contrast to Salmonella typhimurium smooth- and rough-type LPSs, which were toxic in nanogram amounts.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3988339      PMCID: PMC261314          DOI: 10.1128/iai.48.2.359-365.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  THE INFLUENCE OF PHASE ON THE PROTECTIVE POTENCY OF Q FEVER VACCINE.

Authors:  R A ORMSBEE; E J BELL; D B LACKMAN; G TALLENT
Journal:  J Immunol       Date:  1964-03       Impact factor: 5.422

2.  Q FEVER STUDIES IN MONTANA. DETECTION OF ASYMPTOMATIC INFECTION AMONG RESIDENTS OF INFECTED DAIRY PREMISES.

Authors:  L LUOTO; M L CASEY; E G PICKENS
Journal:  Am J Epidemiol       Date:  1965-05       Impact factor: 4.897

3.  Isolation of Coxiella burneti from human placentas.

Authors:  L SYRUCEK; O SOBESLAVSKY; I GUTVIRTH
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1958

4.  The formation of 2-keto-3-deoxyheptonic acid in extracts of Escherichia coli B. I. Identification.

Authors:  A WEISSBACH; J HURWITZ
Journal:  J Biol Chem       Date:  1959-04       Impact factor: 5.157

5.  Phase variation of the Nine Mile and other strains of Rickettsia burneti.

Authors:  M G STOKER; P FISET
Journal:  Can J Microbiol       Date:  1956-05       Impact factor: 2.419

6.  Phase variation of Rickettsia (Coxiella) burneti; study of the antibody response in guinea pigs and rabbits.

Authors:  P FISET
Journal:  Can J Microbiol       Date:  1957-04       Impact factor: 2.419

7.  Air-borne transmission of Q fever: the role of parturition in the generation of infective aerosols.

Authors:  H H WELSH; E H LENNETTE; F R ABINANTI; J F WINN
Journal:  Ann N Y Acad Sci       Date:  1958-06-03       Impact factor: 5.691

8.  Qualitative and quantitative colorimetric determination of heptoses.

Authors:  Z DISCHE
Journal:  J Biol Chem       Date:  1953-10       Impact factor: 5.157

9.  Antigens of Coxiella burnetii. I. Extraction of antigens with non-aqueous organic solvents.

Authors:  R A ORMSBEE; E J BELL; D B LACKMAN
Journal:  J Immunol       Date:  1962-06       Impact factor: 5.422

10.  Q fever studies in southern California; IX. Isolation of Q fever organisms from parturient placenta; of naturally infected dairy cows.

Authors:  L LUOTO; R J HUEBNER
Journal:  Public Health Rep       Date:  1950-04-21       Impact factor: 2.792

View more
  75 in total

1.  Phase variation analysis of Coxiella burnetii during serial passage in cell culture by use of monoclonal antibodies.

Authors:  Akitoyo Hotta; Midori Kawamura; Ho To; Masako Andoh; Tsuyoshi Yamaguchi; Hideto Fukushi; Katsuya Hirai
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 2.  Phase and antigenic variation in bacteria.

Authors:  Marjan W van der Woude; Andreas J Bäumler
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

3.  Role of CD4+ and CD8+ T cells in clearance of primary pulmonary infection with Coxiella burnetii.

Authors:  Amanda J Read; Sara Erickson; Allen G Harmsen
Journal:  Infect Immun       Date:  2010-03-29       Impact factor: 3.441

4.  Coxiella burnetii phase I and II variants replicate with similar kinetics in degradative phagolysosome-like compartments of human macrophages.

Authors:  Dale Howe; Jeffrey G Shannon; Seth Winfree; David W Dorward; Robert A Heinzen
Journal:  Infect Immun       Date:  2010-06-01       Impact factor: 3.441

5.  Coxiella burnetii acid phosphatase inhibits the release of reactive oxygen intermediates in polymorphonuclear leukocytes.

Authors:  J Hill; J E Samuel
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

6.  Coxiella burnetii Inhibits Neutrophil Apoptosis by Exploiting Survival Pathways and Antiapoptotic Protein Mcl-1.

Authors:  Rama Cherla; Yan Zhang; Lindsey Ledbetter; Guoquan Zhang
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

7.  Identification and characterization of an immunodominant 28-kilodalton Coxiella burnetii outer membrane protein specific to isolates associated with acute disease.

Authors:  Guoquan Zhang; Ho To; Kasi E Russell; Laura R Hendrix; Tsuyoshi Yamaguchi; Hideto Fukushi; Katsuya Hirai; James E Samuel
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

8.  Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity.

Authors:  Chen Chen; Erin J van Schaik; Anthony E Gregory; Adam Vigil; Phillip L Felgner; Laura R Hendrix; Robert Faris; James E Samuel
Journal:  J Infect Dis       Date:  2019-07-19       Impact factor: 5.226

9.  Host and Bacterial Factors Control Susceptibility of Drosophila melanogaster to Coxiella burnetii Infection.

Authors:  Reginaldo G Bastos; Zachary P Howard; Aoi Hiroyasu; Alan G Goodman
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

Review 10.  Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.

Authors:  Jeffrey G Shannon; Robert A Heinzen
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.